Reduce el apetito Te hace sentir lleno ms rpidamente y prolonga la sensacin de saciedad despus de comer
Q3: Is GHK-Cu safe for long-term use
Available from: Published Jun 23, 2024
While the formulation patent for oral Wegovy remains valid in major markets such as the United States, the European Union, and Japan until 2039, the company explains that it can circumvent this through its proprietary formulation technology S-PASS. Ildong Pharmaceutical has also set a plan to achieve both technology licensing and entry into Phase 2 clinical trials this year for ID110521156, an oral GLP-1based new drug candidate
Altitude, dehydration, meal-timing changes, and stress can magnify nausea or appetite suppression in GLP-1 users
Nevertheless, it is crucial to consider the potential adverse effects of weight fluctuation after discontinuing these medications, particularly the increased risk of cardiovascular and all-cause mortality in patients with obesity or overweight